PD-1+CD8+ T cell percentage was elevated in HCC patients when compared with healthy individuals (Student t-tests, P = 0.0089, Figure 3E), however, CTLA-4+CD8+ T cells percentage was comparable between patients and controls (Student t-tests, P = 0.278, Figure 3F). This evidence concerns the gene CD8A and hepatocellular carcinoma.